Results 121 to 128 of about 1,192 (128)
Some of the next articles are maybe not open access.

Biomarkers for Alzheimer's Disease: Academic, Industry and Regulatory Perspectives

Nature Reviews Drug Discovery, 2010
Jamie Toombs   +2 more
exaly  

Amyloid-Beta Solubility in the Treatment of Alzheimer’s Disease

New England Journal of Medicine, 2018
M Paul Murphy
exaly  

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

New England Journal of Medicine, 2018
Eric Siemers   +2 more
exaly  

Utility of the Apolipoprotein E Genotype in the Diagnosis of Alzheimer's Disease

New England Journal of Medicine, 1998
Richard Mayeux   +2 more
exaly  

Amyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's Disease

New England Journal of Medicine, 1989
Ralph Martins   +2 more
exaly  

Biomarker Changes During 20 Years Preceding Alzheimer’s Disease

New England Journal of Medicine
Jianping Jia, Jihui Lyu, Yuye Ning
exaly  

Home - About - Disclaimer - Privacy